V-PLEX COVID-19 Coronavirus Panel 3 (ACE2) Kit - Electrochemiluminescence (ECL) Assay

The V-PLEX COVID-19 Coronavirus Panel 3 (ACE2) Kit is a multiplex neutralization assay that measures the antibodies capable of blocking the binding of angiotensin-converting enzyme 2 (ACE2) to the SARS-CoV-2 Spike and RBD antigens. The Panel serves as a high-throughput alternative to traditional neutralization assays. It includes nine (9) important antigens related to SARS-CoV-2, SARS-1, MERS, circulating Coronaviruses, and other respiratory diseases: HCoV-229E Spike, HCoV-HKU1 Spike, HCoV-OC43 Spike, HCoV-NL63 Spike, SARS-CoV-1 Spike, SARS-CoV-2 N, MERS-CoV Spike, SARS-CoV-2 S1 RBD, and SARS-CoV-2 Spike.

Please contact us at for specific academic pricing.

Background

V-PLEX validated immunoassays deliver reproducible, reliable results to support the most demanding long-term studies. Offering exceptional dynamic range, high sensitivity, and lot-to-lot consistency, V-PLEX assays are available as individual analyte kits and in preconfigured and custom multiplex panels.

· Benefits: Provides confidence and reliability. Analytically validated with guaranteed performance specifications
· Format: Lot-matched kits
· Multiplex: Fixed validated panels
· Sample compatibility: Serum, plasma, cell culture supernatants, urine; CSF for neurobiology products